
Shionogi Inc. (U.S.) is dedicated to developing innovative treatments to improve patients' lives globally, with a focus on addressing health challenges like antimicrobial resistance and COVID-19. The company has a history of introducing novel antibiotics and medications for HIV and influenza, and is currently advancing clinical programs in Fragile X syndrome, acute ischemic stroke, metabolic disorders, and oncology. Shionogi's commitment to impactful patient care is driven by strategic partnerships with industry leaders and academic institutions.
Shionogi is seeking a motivated Head of Business Development to drive strategic growth in Infectious Diseases treatment within France. This role involves developing and implementing business plans for key accounts, forging strong relationships with stakeholders, and leveraging data to guide strategy and monitor performance. The company is dedicated to protecting population health and promoting innovation in infectious diseases.
Shionogi Inc. (U.S.) is dedicated to developing innovative treatments to improve patients' lives globally, with a focus on addressing health challenges like antimicrobial resistance and COVID-19. The company has a history of introducing novel antibiotics and medications for HIV and influenza, and is currently advancing clinical programs in Fragile X syndrome, acute ischemic stroke, metabolic disorders, and oncology. Shionogi's commitment to impactful patient care is driven by strategic partnerships with industry leaders and academic institutions.